Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads
- 9 September 2012
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 20 (12) , 3033-3042
Abstract
Venous thromboembolism (VTE) and renal insufficiency are common in cancer patients. Prompt treatment is necessary to reduce the high rates of VTE-related mortality and morbidity. VTE prophylaxis is underused in cancer patients. We review current recommendations for the treatment and prevention of VTE in cancer patients and discuss low molecular weight heparin (LMWH) use in cases of renal failure. This study is a retrospective literature review. There are few published recommendations for LMWH use in cancer patients with renal insufficiency. Treatment guidelines largely follow recommendations for other patients with renal failure. Enoxaparin therapy is complicated by the need for regular monitoring of renal function and anti-Xa levels and for dosage adjustment to prevent bleeding. Few data are available to support the systematic use of dalteparin. Tinzaparin is least likely to bioaccumulate in patients with renal failure. VTE is the second most common cause of death in cancer patients. Renal insufficiency is present in 50–60 % of cancer patients. Data from renal patients suggest that tinzaparin may be safe and effective for VTE treatment and prevention in cancer patients with renal failure.Keywords
This publication has 64 references indexed in Scilit:
- Cancer and renal insufficiency results of the BIRMA studyBritish Journal of Cancer, 2010
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular diseaseJournal of Internal Medicine, 2010
- Cancer-Associated Thrombosis~!2009-11-10~!2009-12-11~!2010-02-22~!The Open Cardiovascular Medicine Journal, 2010
- 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working groupAnnals of Oncology, 2009
- Epidemiology of cancer-related venous thromboembolismBest Practice & Research Clinical Haematology, 2009
- Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With CancerArchives of internal medicine (1960), 2008
- Prevalence of renal insufficiency in breast cancer patients and related pharmacological issuesBreast Cancer Research and Treatment, 2008
- Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)Critical Reviews in Oncology/Hematology, 2006
- Tinzaparin SodiumDrugs, 2004
- Increased Incidence of Malignancy in Chronic Renal FailureNephron, 1977